TERUMO CORPORATION, ASHITAKA
Manufacturer adverse-event records for TERUMO CORPORATION, ASHITAKA come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 1997–2026 · thin-book · elevated Death-code · balanced
Volume signature
TERUMO CORPORATION, ASHITAKA is a thinner MAUDE footprint
TERUMO CORPORATION, ASHITAKA accounts for 3,865 FDA MAUDE reports (#425 of 434, thin-book tercile). Death-coded event_type share is 1.40% (elevated); Injury share 43.4% (balanced).
What the volume reading shows for TERUMO CORPORATION, ASHITAKA
The standout signal for TERUMO CORPORATION, ASHITAKA is filing volume: 3,865 adverse-event reports in FDA MAUDE (#425 of 434, thin-book). Death-coded event_type share sits at 1.40% (elevated).
As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.
Reports span 20 device types, led in this extract by Malfunction at 2,106 (54.5% of event_type total). Peak single-year volume reaches 335 reports across 30 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.